Skip to content

RESTORE-TAVI Pilot

A Pilot Study Assessing the Feasibility and Effectiveness of a Perioperative Multi-component Intervention in Patients With Acute Decompensated Aortic Stenosis Undergoing Urgent Transcatheter Aortic Valve Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06121921
Enrollment
40
Registered
2023-11-08
Start date
2024-06-07
Completion date
2025-05-01
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Frailty

Brief summary

This is a pilot randomised control study assessing the feasibility and effectiveness of a perioperative multi-component intervention aimed at reducing adverse hospital events and improving functional outcomes in patients with acute decompensated aortic stenosis undergoing urgent transcatheter aortic valve implantation compared to standard care. The intervention will consist of physical rehabilitation, delirium prevention, nutritional supplementation and anaemia correction (where indicated). The primary objective is to determine the feasibility and safety of delivering this intervention Secondary objectives include investigating the impact on adverse hospital events such as hospital-acquired disability and post-TAVI delirium, and on health-related quality of life and functional recovery following TAVI.

Interventions

OTHERPerioperative multi-component intervention

Physical Component Self-directed daily non-ambulatory exercise programme, comprising: * Rubber ball squeezes (3 sets of 12 reps, per hand) * Bicep curls (3 sets of 12 reps) * Leg extensions (3 sets of 12 reps) * Chair rises (3 sets of 12 reps) * Arm stretches (3 sets of 3 reps) Additional encouragement to mobilise Cognitive Component: Delirium prevention strategies including orientation, hydration, bowel/bladder function, infection control, analgesia, polypharmacy and cognitive stimulation Nutritional Component: * Formal dietician review if MUST score ≥ 2 * IV ferritin if LVEF \<45% and serum ferritin \<100ng/mL or ferritin 100-299ng/mL with TSAT \<20%

Sponsors

Imperial College London
CollaboratorOTHER
Barts & The London NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 70 years 2. Ability to provide written informed consent 3. Ability to speak English

Exclusion criteria

1. Clinical instability defined as requiring use of inotropes/mechanical-circulatory support during admission or post-cardiac arrest 2. Active delirium (4AT score ≥ 4) at time of recruitment 3. Parkinson's disease (Hoehn & Yahr stage 3-5) 4. Recent stroke (within 7 days preceding recruitment) 5. Terminal condition (e.g. metastatic cancer) with life expectancy \< 12 months 6. Clinical unsuitable for recruitment to trial according to the discretion of the research team

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: Recruitment rates1 yearAverage number of patients per month willing to give informed consent and be randomised into a trial of a perioperative frailty intervention
Feasibility: SafetyOn discharge: e.g. 2-7 daysIn-hospital adverse events (e.g. falls, ischaemia, arrhythmia, acute kidney injury), in-hospital mortality

Secondary

MeasureTime frameDescription
Changes in health-related quality of life30 daysMeasured using EQ-5D-5L at baseline and 30 days post discharge via telephone
Changes in physical frailty30 daysBy comparing SARC-F (strength, assistance with walking, rise form a chair, climb stairs and falls) questionnaire at baseline and 30 days (via telephone) after discharge
Change in cognitive function30 daysAssessed using T-MoCA at admission and 30 days post discharge via telephone
Change in mood30 daysAssessed using HADS at admission and 30 days post discharge via telephone
Incidence of hospital-acquired disability30 daysdefined as loss of ≥ 1 ADL at discharge compared to admission; and followed-up at 30 days after discharge
Length of hospital stayOn discharge: e.g. 2-7 daysDuration of inpatient stay at tertiary centre
Discharge destinationOn discharge: e.g. 2-7 dayse.g. to patient's own home, long-term care facility or district general hospital
Unplanned readmissions30 daysMeasured at 30 days post discharge from tertiary centre using hospital records and patient telephone-interview
Mortality30 daysMeasured at 30 days post discharge using hospital records and NHS Spine database
Incidence of falls during hospitalisationOn discharge: e.g. 2-7 days
Incidence of deliriumDaily (during inpatient admission) until the seventh day post-TAVI and then twice weekly thereafterAssessed daily during hospitalisation by using 4AT until the seventh day post-TAVI and then twice weekly thereafter

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026